Your browser doesn't support javascript.
loading
Homologous Recombination DNA Repair Pathway Disruption and Retinoblastoma Protein Loss Are Associated with Exceptional Survival in High-Grade Serous Ovarian Cancer.
Garsed, Dale W; Alsop, Kathryn; Fereday, Sian; Emmanuel, Catherine; Kennedy, Catherine J; Etemadmoghadam, Dariush; Gao, Bo; Gebski, Val; Garès, Valérie; Christie, Elizabeth L; Wouters, Maartje C A; Milne, Katy; George, Joshy; Patch, Ann-Marie; Li, Jason; Arnau, Gisela Mir; Semple, Timothy; Gadipally, Sreeja R; Chiew, Yoke-Eng; Hendley, Joy; Mikeska, Thomas; Zapparoli, Giada V; Amarasinghe, Kaushalya; Grimmond, Sean M; Pearson, John V; Waddell, Nicola; Hung, Jillian; Stewart, Colin J R; Sharma, Raghwa; Allan, Prue E; Rambau, Peter F; McNally, Orla; Mileshkin, Linda; Hamilton, Anne; Ananda, Sumitra; Grossi, Marisa; Cohen, Paul A; Leung, Yee C; Rome, Robert M; Beale, Philip; Blomfield, Penny; Friedlander, Michael; Brand, Alison; Dobrovic, Alexander; Köbel, Martin; Harnett, Paul; Nelson, Brad H; Bowtell, David D L; deFazio, Anna.
Afiliación
  • Garsed DW; Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.
  • Alsop K; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Victoria, Australia.
  • Fereday S; Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.
  • Emmanuel C; Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.
  • Kennedy CJ; Centre for Cancer Research, The Westmead Institute for Medical Research, Sydney, New South Wales, Australia.
  • Etemadmoghadam D; Department of Gynaecological Oncology, Westmead Hospital, Westmead, New South Wales, Australia.
  • Gao B; The University of Sydney, Sydney, New South Wales, Australia.
  • Gebski V; Centre for Cancer Research, The Westmead Institute for Medical Research, Sydney, New South Wales, Australia.
  • Garès V; Department of Gynaecological Oncology, Westmead Hospital, Westmead, New South Wales, Australia.
  • Christie EL; Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.
  • Wouters MCA; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Victoria, Australia.
  • Milne K; Department of Pathology, University of Melbourne, Victoria, Australia.
  • George J; Centre for Cancer Research, The Westmead Institute for Medical Research, Sydney, New South Wales, Australia.
  • Patch AM; Crown Princess Mary Cancer Care Centre, Westmead Hospital, Sydney, New South Wales, Australia.
  • Li J; NHMRC Clinical Trials Centre, Sydney, New South Wales, Australia.
  • Arnau GM; NHMRC Clinical Trials Centre, Sydney, New South Wales, Australia.
  • Semple T; Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.
  • Gadipally SR; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Victoria, Australia.
  • Chiew YE; Deeley Research Centre, British Columbia Cancer Agency, Victoria, British Columbia, Canada.
  • Hendley J; Deeley Research Centre, British Columbia Cancer Agency, Victoria, British Columbia, Canada.
  • Mikeska T; The Jackson Laboratory for Genomic Medicine, Farmington, Connecticut.
  • Zapparoli GV; QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia.
  • Amarasinghe K; Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.
  • Grimmond SM; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Victoria, Australia.
  • Pearson JV; Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.
  • Waddell N; Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.
  • Hung J; Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.
  • Stewart CJR; Centre for Cancer Research, The Westmead Institute for Medical Research, Sydney, New South Wales, Australia.
  • Sharma R; Department of Gynaecological Oncology, Westmead Hospital, Westmead, New South Wales, Australia.
  • Allan PE; Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.
  • Rambau PF; Translational Genomics and Epigenomics Laboratory, Olivia Newton-John Cancer Research Institute, Heidelberg, Victoria, Australia.
  • McNally O; School of Cancer Medicine, La Trobe University, Bundoora, Victoria, Australia.
  • Mileshkin L; Translational Genomics and Epigenomics Laboratory, Olivia Newton-John Cancer Research Institute, Heidelberg, Victoria, Australia.
  • Hamilton A; School of Cancer Medicine, La Trobe University, Bundoora, Victoria, Australia.
  • Ananda S; Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.
  • Grossi M; University of Melbourne Centre for Cancer Research, The University of Melbourne, Victoria, Australia.
  • Cohen PA; QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia.
  • Leung YC; QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia.
  • Rome RM; Department of Gynaecological Oncology, Westmead Hospital, Westmead, New South Wales, Australia.
  • Beale P; Department of Histopathology, King Edward Memorial Hospital, Perth and the University of Western Australia, Crawley, Western Australia, Australia.
  • Blomfield P; Department of Anatomical Pathology, Westmead Hospital, Westmead, New South Wales, Australia.
  • Friedlander M; The University of Sydney, Sydney, New South Wales, Australia.
  • Brand A; Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.
  • Dobrovic A; Department of Pathology and Laboratory Medicine, Foothill Medical Center, University of Calgary, Calgary, Canada.
  • Köbel M; Department of Obstetrics and Gynaecology, The University of Melbourne, Victoria, Australia.
  • Harnett P; The Royal Women's Hospital, Parkville, Victoria, Australia.
  • Nelson BH; Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.
  • Bowtell DDL; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Victoria, Australia.
  • deFazio A; Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.
Clin Cancer Res ; 24(3): 569-580, 2018 02 01.
Article en En | MEDLINE | ID: mdl-29061645
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Neoplasias Ováricas / Proteína de Retinoblastoma / Cistadenocarcinoma Seroso / Reparación del ADN por Recombinación Tipo de estudio: Diagnostic_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Aged / Aged80 / Female / Humans / Middle aged Idioma: En Revista: Clin Cancer Res Asunto de la revista: NEOPLASIAS Año: 2018 Tipo del documento: Article País de afiliación: Australia
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Neoplasias Ováricas / Proteína de Retinoblastoma / Cistadenocarcinoma Seroso / Reparación del ADN por Recombinación Tipo de estudio: Diagnostic_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Aged / Aged80 / Female / Humans / Middle aged Idioma: En Revista: Clin Cancer Res Asunto de la revista: NEOPLASIAS Año: 2018 Tipo del documento: Article País de afiliación: Australia